VTGN SCHEDULE 13G/A: SEC filing

Biotechnology Value Fund and affiliated reporting persons

Filed with the SEC on · accession 0000921895-26-003193

VTGN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.0% by the first close after the filing.

Summary of the filing

Biotechnology Value Fund and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 3.7% of Vistagen Therapeutics, primarily through tranche 2 warrants exercisable at $8.877 per share.

Key details

Aggregate shares deemed beneficially owned by BVF Partners L.P. and BVF Inc.$1.7M
Shares deemed beneficially owned by BVF GP Holdings LLC$1.6M
T2 Warrant exercise price per share$9
Reporting person / beneficial ownerBiotechnology Value Fund, L.P.
Investment manager / reporting personBVF Partners L.P.
Issuer / subject companyVistagen Therapeutics, Inc.
Director and officer of bvf inc.Mark N. Lampert

How VTGN stock reacted

Close before

$0.18

Nov 13, 2026

First close after

+2.05%

$0.18

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for VTGN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VTGN?

Click here

Frequently asked questions

What did VTGN file with the SEC on Nov 16, 2026?

VTGN filed a SCHEDULE 13G/A (SEC filing). Biotechnology Value Fund and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 3.7% of Vistagen Therapeutics, primarily through tranche 2 warrants exercisable at $8.877 per share.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did VTGN stock react to this filing?

VTGN closed at $0.18 before the filing and $0.18 on Nov 16, 2026 (+2.05%).

Other VTGN SEC filings

Get alerts when VTGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days